Biotech industry blasts 'misguided' Trump travel ban

Bosses of more than 150 US biotech companies Tuesday criticised US President Donald Trump's travel ban against seven Muslim-majority countries, saying the sector stood to lose talented workers and its global dominance.

Samsung acquires US medical imaging company

South Korea's Samsung Electronics said Tuesday it had bought US medical imaging firm NeuroLogica, as it seeks to explore new growth sources by expanding into the health sector.

How better financing could help create new cancer drugs

The pharmaceuticals industry presents a quandary for potential investors: Major investments in drug development pay off handsomely in a relatively small number of cases, but many other projects deliver no returns at all. ...

Video: The legal battle over CRISPR

CRISPR could potentially engineer super crops, make designer animal models for research and even snip out genetic diseases. Experts say that billions of dollars are at stake.

VCs bet big on Silicon Valley biotech

Companies searching for cures for cancer and testing treatments for crippling genetic diseases are capturing the interest of venture capitalists - and their money - more than at any time in the last seven years.

page 3 from 4